Theranostics Market Growth, Trends & Forecast 2025 | Top key players - Theragnostics Ltd., NuView Life Sciences, Lantheus Holdings, Inc.

The Global Theranostics Market reached USD 1.8 billion in 2022 and is expected to witness lucrative growth by reaching up to USD 4.2 billion by 2031. The global theranostics market is expected to exhibit a CAGR of 11.3% during the forecast period (2024-2031).

The Theranostics Market, as analyzed by DataM Intelligence, offers a comprehensive industry overview backed by in-depth insights, historical trends, and key statistics. The report dives deep into market dynamics and competitive strategies, profiling major players along with their product portfolios, pricing models, financial performance, growth initiatives, and regional presence.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/theranostics-market?sz

The Theranostics Market involves integrated diagnostic and therapeutic technologies designed to personalize medical treatment. It combines targeted therapies with diagnostic tests to identify disease presence, monitor treatment response, and improve patient outcomes. This market is driven by advances in molecular imaging, biomarkers, and precision medicine, offering more effective, tailored treatment options for diseases like cancer and neurological disorders.

Major players in the Theranostics Market

The prominent players in Theranostics market research report are: GE Healthcare, Jubilant Pharmova Limited (Jubilant Pharma Limited), Theragnostics Ltd., NuView Life Sciences, Lantheus Holdings, Inc., CapVest Limited (Curium Pharma), Clarity Pharmaceuticals, Cardinal Health, LLC, Advanced Accelerator Applications, and ITM Isotopen Technologien München AG among others.

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Key Development

On February 22, 2022, Theragnostics announced that NephroScan, its radiodiagnostic imaging drug used to aid in the evaluation of renal parenchymal disorders in both adult and pediatric patients-including term neonates-received marketing approval from the U.S. Food and Drug Administration (FDA).

Earlier, on February 10, 2022, Theragnostics revealed that its novel therapeutic agent, I-123 PARPi (THG-009), was granted an Innovation Passport by the UK Medicines and Healthcare Products Regulatory Agency (MHRA). This recognition supports its development for treating primary and recurrent Glioblastoma Multiforme (GBM) under the MHRA's Innovative Licensing and Access Pathway (ILAP), a program launched in January 2021 to speed up access to groundbreaking medicines in the UK.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/theranostics-market

Market Segments

By Application: Oncology, Neurological Disorder, Cardiovascular Disease and Others.

By Radioisotopes: Technetium-99, Gallium-68, Lutetium (Lu) 177, Iodine-131, Zirconium-89 , Y-90 and Others.

By End User: Hospitals, Cancer Research Institutes, Diagnostic Centers and Others.

The Theranostics industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Regions Covered:

The global Theranostics Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.